Plasma Diafiltration Therapy in Patients With Postoperative Liver Failure

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 4, 2011, Pages 406-410

  Nakae, Hajime ^a   Eguchi, Yutaka ^c   Yoshioka, Toyokazu ^b   Yoshimura, Noriko ^d   Isono, Motohide ^d  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nishi Kyoto Hospital   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d Otsu Municipal Hospital   (Japan)

Author keywords

MELD score; Plasma diafiltration; Postoperative liver failure

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; NAFAMSTAT MESILATE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MALE; PLASMA DIAFILTRATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE LIVER FAILURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PURIFICATION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BILIRUBIN; BLOOD PROTEINS; BLOOD UREA NITROGEN; CREATININE; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051997197     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00969.x     Document Type: Article

References (14)

1. Nakae H, Zheng Y-J, Wada H etal. Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure. Eur Surg Res 2003;35:61-6.
2. Yonekawa C, Nakae H, Tajimi K etal. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artif Organs 2005;29:324-8.
3. ®-a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-90.
4. Evenepoel P, Laleman W, Wilmer A etal. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 2006;30:276-84.
5. Faenza S, Baraldi O, Bernardi M etal. MARS and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc 2008;40:1169-71.
6. Nakae H, Igarashi T, Tajimi K etal. A case report of hepatorenal syndrome treated with plasma diafiltration (Selective plasma filtration with dialysis). Ther Apher Dial 2007;11:391-5.
7. Nakae H, Igarashi T, Tajimi K etal. A case of pediatric fulminant hepatitis treated with plasma diafiltration. Ther Apher Dial 2008;12:329-32.
8. Nakae H. Blood purification for intoxication. Contrib Nephrol 2010;166:93-9.
9. Nakae H, Eguchi Y, Saotome T etal. Multicenter study of plasma diafiltration in patients with acute liver failure. Ther Apher Dial 2010;14:444-50.
10. Kamath PS, Wiesner RH, Malinchoc M etal. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
11. Dhiman RK, Jain S, Maheshwari U etal. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl 2007;13:814-21.
12. Li LJ, Liu XL, Xu XW etal. Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis. Ther Apher Dial 2005;9:396-401.
13. Ho DW, Fan ST, To J etal. Selective plasma filtration for treatment of fulminant hepatic failure induced by d-galactosamine in a pig model. Gut 2002;50:869-76.
14. Rozga J, Umehara Y, Trofimenko A etal. A novel plasma filtration therapy for hepatic failure: preclinical studies. Ther Apher Dial 2006;10:138-44.